Literature DB >> 8733376

An immunohistochemical study of the dermal infiltrate and epidermal staining for interleukin 1 in 12 cases of Sweet's syndrome.

J F Bourke1, J L Jones, A Fletcher, R A Graham-Brown.   

Abstract

Interleukin 1 (IL-1) has been proposed as a possible mediator in Sweet's syndrome. We examined all cases of Sweet's syndrome (n = 12) presenting to the department over a 10-year period, from 1982 to 1992, for the presence of IL-1 and also assessed the nature of the dermal inflammatory infiltrate in those cases. Staining for IL-1 alpha and IL-1 beta was stronger in control tissues than in Sweet's syndrome. This may possibly be explained by the release of IL-1 alpha and IL-1 beta into the dermis in Sweet's syndrome. Contrary to recent reports, we found that neutrophils predominated in all cases examined, although histiocytes were present in increased numbers indicating their possible role in the pathophysiology of Sweet's syndrome.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8733376

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  7 in total

1.  [IL-1 antagonists].

Authors:  I Kötter; G Horneff
Journal:  Z Rheumatol       Date:  2010-09       Impact factor: 1.372

Review 2.  Idiopathic, Refractory Sweet's Syndrome Associated with Common Variable Immunodeficiency: a Case Report and Literature Review.

Authors:  Quindelyn S Cook; Carlton J Zdanski; Craig N Burkhart; Paul B Googe; Patrick Thompson; Eveline Y Wu
Journal:  Curr Allergy Asthma Rep       Date:  2019-05-14       Impact factor: 4.919

3.  Periodic Fever: A Review on Clinical, Management and Guideline for Iranian Patients - Part II.

Authors:  Zahra Ahmadinejad; Sedigeh Mansouri; Vahid Ziaee; Yahya Aghighi; Mohammad-Hassan Moradinejad; Fatemeh Fereshteh-Mehregan
Journal:  Iran J Pediatr       Date:  2014-06       Impact factor: 0.364

4.  Atypical Histiocyte-Rich Sweet's Syndrome.

Authors:  Sharon Chi; Marcia Leung; Mark Carmichael; Michael Royer; Sunghun Cho
Journal:  Case Rep Dermatol Med       Date:  2017-10-18

5.  Recurrent Subcutaneous Sweet's Disease in a Myelofibrosis Patient Treated with Ruxolitinib before Allogeneic Stem Cell Transplantation.

Authors:  Teppei Sakoda; Yoko Kanamitsu; Yasuo Mori; Kensuke Sasaki; Etsuko Yonemitsu; Konosuke Nagae; Goichi Yoshimoto; Kenjiro Kamezaki; Koji Kato; Katsuto Takenaka; Toshihiro Miyamoto; Masutaka Furue; Hiromi Iwasaki; Koichi Akashi
Journal:  Intern Med       Date:  2017-08-21       Impact factor: 1.271

6.  Ptpn6 inhibits caspase-8- and Ripk3/Mlkl-dependent inflammation.

Authors:  Mary Speir; Cameron J Nowell; Alyce A Chen; Joanne A O'Donnell; Isaac S Shamie; Paul R Lakin; Akshay A D'Cruz; Roman O Braun; Jeff J Babon; Rowena S Lewis; Meghan Bliss-Moreau; Inbar Shlomovitz; Shu Wang; Louise H Cengia; Anca I Stoica; Razq Hakem; Michelle A Kelliher; Lorraine A O'Reilly; Heather Patsiouras; Kate E Lawlor; Edie Weller; Nathan E Lewis; Andrew W Roberts; Motti Gerlic; Ben A Croker
Journal:  Nat Immunol       Date:  2019-12-09       Impact factor: 25.606

Review 7.  Sweet's syndrome--a comprehensive review of an acute febrile neutrophilic dermatosis.

Authors:  Philip R Cohen
Journal:  Orphanet J Rare Dis       Date:  2007-07-26       Impact factor: 4.123

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.